Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass

Exclusion Criteria

• •Diabetes on anti-diabetic treatment (insulin and/or non-insulin agents)
• •Genito-urinary infection, if not treated successfully
• •Chronic kidney disease (defined as CKD-EPI eGFR \< 60 mL/min per 1.73 m2 body surface area)
• •Pregnant and lactating women (urine pregnancy test to be performed for women of childbearing potential \[defined as women who are not surgically sterilized/ hysterectomized, and/ or who are postmenopausal for less than 12 months\]) or women of childbearing potential that refuse to use an effective contraceptive method \[birth control pill or intrauterine device (IUD)\]).
• •Inability to understand and follow the protocol
• •Known allergy to the study drug
• •Participation in another interventional clinical trial overlapping with the current trial